NCT03073265View on ClinicalTrials.gov

Apixaban Validation Study - Additional Study on Fresh Samples

CompletedOBSERVATIONAL

Enrollment

109

Participants

Timeline

Start Date

May 8, 2017

Primary Completion Date

November 1, 2017

Study Completion Date

November 1, 2017

Conditions

Anticoagulation With Apixaban

Interventions

DEVICE

STA-Apixaban Calibrator & Control

Measurement of apixaban level will be done using anti-Xa assay (IVD).

Trial Locations (2)

18101

Lehigh Valley Health Nrwork, Allentown

27401

Moses Cone Memorial Hospital, Greensboro

Sponsors

Lead Sponsor

Diagnostica Stago

All Listed Sponsors

lead

Diagnostica Stago

INDUSTRY